# Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/evaluation-of-the-safety-and-immunogenicity-of-synthetic-a-42-an1792-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Antony Bayer,R. Morris Bullock,Roy Jones,David Wilkinson,K. R. Paterson,Lisa Jenkins,S. Babli Millais,Stephen Donoghue |
| Citations | 352 |
| DOI | 10.1212/01.wnl.0000148604.77591.67 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1991989649 |
| PMID | 15642910 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Roy Jones](https://scholariq.org/researchers/roy-jones/)

## Paper journal

- [Neurology](https://scholariq.org/journals/neurology/)

## Paper primary topic

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)

## Paper topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Medicinal Plants and Neuroprotection](https://scholariq.org/topics/medicinal-plants-and-neuroprotection/)
- [Advanced Drug Delivery Systems](https://scholariq.org/topics/advanced-drug-delivery-systems/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.